
    
      After being informed about the study and potential risks, all parents giving written informed
      consent the principal investigator will determine the eligibility for study entry. Patients
      who met the eligibility requirements will be randomized in a double-blind manner in a 1:1
      ratio to fortified breast milk with higher fat composition to fortified breast milk with
      higher carbohydrate composition. Both groups will receive a stable protein composition. The
      participants will receive the intervention for 3 consecutive weeks.
    
  